arrow
H

Hanne Hillen

vib-ku leuven center for cancer biology
H指数:5
被引数:529

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hippo signaling drives mesenchymal cell fate and heterogeneity in liver cancer

Hippo信号通路驱动肝癌中间充质细胞的命运和异质性

2026-10-150
OAAI
Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma

激动性GITR治疗可增强胰腺导管腺癌的抗肿瘤免疫反应并抑制肿瘤进展

2026-02-010
OAAI
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation

脂肪性肝病诱导YAP/TAZ驱动的细胞竞争,该竞争可抑制肿瘤起始

2025-06-060
PREAI
A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models
2023-09-2510
OA
Hippo signaling instructs ectopic but not normal organ growth

Hippo信号指示异位但不正常的器官生长

Science
IF45.8
2022-01-010
OA
Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis
2021-02-0144
OAAI